doctor caring for Ebola patients in rural Liberia says he is successfully
treating them with the HIV med Epivir (lamivudine).
Such an increase could help save the lives of more than 1.8 million people nationwide each year.
To achieve this outcome, a fast-track strategy would need to be implemented.
Saturday, September 27, is NGMHAAD.
To mark the occasion, the group is holding an event Thursday, September 25, in San Francisco.
It will take place in Washington, DC, April 13 to 14.
About 8,000 people living with HIV will receive access to expanded services.
A memorial service will be held Saturday, September 27.
In 2013, five runners completed the first trek.
Thursday, September 18, is the seventh annual NHAAAD.
It was developed with input from more than 100 HIV-positive people.
Repairs are up to $1 million on the high end.
They have requested a written update within 30 days.
The coalition seeks treatment for everyone living with hepatitis C.
A court-approved settlement was reached July 31 and started September 4.
The company has agreed to pay $25,000 in relief.
About 30 percent of the 1.1 million Americans living with HIV also have HCV.
The grant will directly support the amfAR Countdown to a Cure research initiative.
The grant will help fund a Phase I clinical trial in humans.
Smoking cessation products have replaced tobacco on the shelves.